SERTRALINE HYDROCHLORIDE

Product NDC
53002-4215
11-digit product format
530024215
Labeler code
53002
Product ID
53002-4215_dfc0f5e1-2242-41bc-ad38-a36c424b4043
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SERTRALINE HYDROCHLORIDE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA202825
Marketing category
ANDA
Marketing start
2017-02-09
Marketing end
0000-00-00
Substance
SERTRALINE HYDROCHLORIDE
Active strength
100 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
UTI8907Y6XSERTRALINE HYDROCHLORIDE79559-97-0SERTRALINE HYDROCHLORIDE

Packages

Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
53002-4215-053002421500100 TABLET, FILM COATED in 1 BOTTLE (53002-4215-0) 2021-01-010000-00-00NoNoCurrent
53002-4215-35300242150330 TABLET, FILM COATED in 1 BOTTLE (53002-4215-3) 2021-01-010000-00-00NoNoCurrent
53002-4215-65300242150660 TABLET, FILM COATED in 1 BOTTLE (53002-4215-6) 2021-01-010000-00-00NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
SERTRALINE HYDROCHLORIDERPK Pharmaceuticals, Inc.2022-03-30HUMAN PRESCRIPTION DRUG LABEL1